Italian multicenter study on accuracy of 18F-FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin ’s Lymphoma

This study investigated the utility of F-18-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in assessing bone marrow involvement (BMI) compared to bone marrow biopsy (BMB) in newly diagnosed pediatric Hodgkin ’s lymphoma (HL). 18F-FDG PET/CT shows high diagnostic performance in evaluating BMI in pediatric HL. BMB should be ideally reserved for patients with 18F-FDG PET/CT presenting doubtful bone marrow findings.

Source: Clinical Lymphoma, Myeloma and Leukemia - April 14, 2018 Category: Hematology Authors: A. Cistaro, L. Cassalia, C. Ferrara, N. Quartuccio, L. Evangelista, M. Bianchi, F. Fagioli, G. Bisi, S. Baldari, A. Zanella, M. Pillon, P. Zucchetta, M. Burei, A. Sala, L. Guerra, P. Guglielmo, R. Burnelli, S. Panareo, F. Scalorbi, I. Rambaldi, A. Piccard Tags: Original Study Source Type: research